Tracks how patients with glaucoma take their prescribed eye drops using a smart device
Tests a connected eye-drop device in adults with glaucoma or ocular hypertension.
Plain-language title generated from the registry record
Registry title: Real-world Study to Assess Adherence to IOP Lowering Therapy in Patients With Glaucoma or Ocular Hypertension Using CONNECTDROP®
Key facts
- Where
- Bologna, Catania, Corigliano, Genova, Lecce, Lucca, Modena, Morrovalle, Naples, Roma, San Donà di Piave, Sassari, and Torino, ItalySee the 15 sites
Where in Italy
- Studio Oculistico D'AzeglioBologna, ItalyTaking people
- Centro Medico Polispecialistico Di MaitaCatania, ItalyTaking people
- Studio Medico Oculistico Dr.ssa Rosa SCHIAVELLI s.r.l.Corigliano, ItalyTaking people
- Ospedale Policlinico S. Martino-IRCCS Clinica Oculistica Università di GenovaGenova, ItalyTaking people
- Centro Corporis LabLecce, ItalyTaking people
- Studi Oculistici - Dott. Andrea BedeiLucca, ItalyTaking people
- Poliambulatorio Chirurgico Modenese Eyecare ClinicModena, ItalyTaking people
- Centro Oculistico Ramovecchi S.r.l.Morrovalle, ItalyTaking people
- Dipartimento di Neuroscienze e Scienze Riproduttive ed Odontostomatologiche, Università degli studi di Napoli Federico IINaples, ItalyTaking people
- Ambulatorio Oculistica Ospedale San Carlo di Nancy -GVM-Roma, ItalyNot yet recruiting
- IRCCS Fondazione G.B. BiettiRoma, ItalyTaking people
- UOSD di Oculistica, Fondazione PTV Policlinico Tor VergataRoma, ItalyTaking people
- Ospedale San Donà Piave, Aussl 4 Veneto Orientale, UOC OculisticaSan Donà di Piave, ItalyTaking people
- AOU Sassari Clinica OculisticaSassari, ItalyTaking people
- Humanitas Gradenigo U.O. OculisticaTorino, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Laboratoires Thea
- Trial code
- NCT07206628
- Record updated
- 17 August 2026
- Original description
The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma or OHT already treated with IOP-lowering eye drops using connected device CONNECTDROP®Read full original descriptionShow less
Real-world Study to Assess Adherence to IOP Lowering Therapy in Patients With Glaucoma or Ocular Hypertension Using CONNECTDROP®: the GRANITE Study (Glaucoma tReatment AdhereNce wIth connecTed dEvice in Italy)
The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma or OHT already treated with IOP-lowering eye drops using connected device CONNECTDROP®
The main questions it aims to answer are:
* The mean annual adherence rate, defined as the percentage of the prescribed doses taken by the patient * The adherence profile of each patient * The association between the adherence profile, the objective adherence data and the clinical data.
Participants will use the connected device CONNECTDROP® associated with the smartphone application on a daily basis.
Inclusion: Adult patient (≥ 18 years old), man or woman; Patient with a diagnosis of bilateral open angle glaucoma or OHT; Patients being prescribed with glaucoma eye drops in EASYGRIP® bottle for at least 6 weeks in monotherapy; Patient willing to participate in the study; Patient who consents for data collection in the frame of the study.
Exclusion: Patient receiving another ocular treatment for a chronic condition (i.e. regular instillations for several months); Pregnant and/or lactating woman; Protected patient: adult under guardianship, curatorship or other protection legal, deprived of liberty by judicial or administrative decision.